Back to mobile site

Piper Sandler Reiterates Overweight Rating on Viking Therapeutic (VKTX)

July 7, 2026 7:52 AM EDT Send to a Friend
Piper Sandler analyst Biren Amin reiterated an Overweight rating and $71.00 price target on Viking Therapeutic (NASDAQ: VKTX).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login